Awash in red ink, life sciences firm Avivagen seeks new CEO to spark scaleup bid

Cows eating

In financial filings this week, Ottawa-based company says it brought in $939,000 in revenues in its fiscal year ending Oct. 31, 2022, down from about $1.3 million the previous year.

Already an Insider? Log in

Get Instant Access to This Article

Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more.

Get our email newsletters

Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.

By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.